Stay updated on Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2; this appears to be a technical page update with no changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page adds a 'Show glossary' option and includes minor textual/capitalization updates to QC-related labels and revision information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check56 days agoChange DetectedThe Related Topics section now includes links for Ovarian cancer and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a footer revision note: 'Revision: v3.3.3'. Removed footer links and references to 'HHS Vulnerability Disclosure', 'Ovarian cancer', and 'MedlinePlus Genetics', as well as 'Revision: v3.3.2'.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.